Methods of production of products of metabolic pathways

US9719122B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9719122-B2
Application numberUS-201314415612-A
CountryUS
Kind codeB2
Filing dateJul 17, 2013
Priority dateJul 18, 2012
Publication dateAug 1, 2017
Grant dateAug 1, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A plurality of isolated polynucleotide sequences encoding enzymes of the astaxanthin pathway is disclosed. The polynucleotides include: (i) a polynucleotide which encodes Phytoene dehydrogenase (crtI) and a first transcriptional regulatory sequence; (ii) a polynucleotide which encodes Beta-lycopene cyclase (lcy-B) and a second transcriptional regulatory sequence; (iii) a polynucleotide which encodes Beta-carotene ketolase (crtW) and a third transcriptional regulatory sequence; and wherein the first, second and third regulatory sequence are selected such that the expression of the Icy-B and the crtW is greater than a level of expression of the crtI. Methods of generating astaxanthin using the plurality of polynucleotide are also disclosed as well as bacterial cells comprising high levels of astaxanthin.

First claim

Opening claim text (preview).

What is claimed is: 1. A kit comprising a plurality of isolated polynucleotide sequences encoding enzymes of the astaxanthin pathway comprising: (i) a polynucleotide which encodes Phytoene dehydrogenase (crtI) operatively linked to a first ribosome binding site (RBS); (ii) a polynucleotide which encodes Beta-lycopene cyclase (lcy-B) operatively linked to a second RBS; (iii) a polynucleotide which encodes Beta-carotene ketolase (crtW) operatively linked to a third RBS; (iv) a polynucleotide which encodes Isopentenyl pyrophosphate (idi) operatively linked to a fourth RBS; (v) a polynucleotide which encodes Geranylgeranyl pyrophosphate synthase (crtE) operatively linked to a fifth RBS; (vi) a polynucleotide which encodes Prephytoene pyrophosphate synthase operatively linked to a sixth RBS; and (vii) a polynucleotide which encodes Beta-carotene hydroxylase (crtZ) operatively linked to a seventh RBS, wherein the second RBS and the third RBS enhance expression of an operatively linked fluorescent reporter polypeptide sequence in a vector within a suitable host cell at least five times more than the first RBS enhances expression of said operatively linked fluorescent reporter polypeptide sequence in the same position of said vector in said host cell, as measured by flow cytometry. 2. The kit of claim 1 , wherein said second RBS and said third RBS enhance expression of the operatively linked fluorescent reporter polypeptide sequence ten times more than the first RBS enhances expression of said fluorescent reporter polypeptide sequence which is operatively linked thereto, as measured by flow cytometry. 3. The kit of claim 1 , wherein the sequence of the first RBS set forth in SEQ ID NO: 4, 5, 6 or 7; wherein the sequence of said second RBS is set forth in SEQ ID NO: 2 or 3; wherein the sequence of said third RBS is set forth in SEQ ID NO: 2 or 3. 4. The kit of claim 3 , wherein the sequence of said fourth RBS is set forth in SEQ ID NO: 5; wherein the sequence of said fifth RBS is set forth in SEQ ID NO: 5; wherein the sequence of said sixth RBS is set forth in SEQ ID NO: 3; wherein the sequence of said first RBS is set forth in SEQ ID NO: 7; wherein the sequence of said second RBS is set forth in SEQ ID NO: 2; wherein the sequence of said third RBS is set forth in SEQ ID NO: 3; and wherein the sequence of said seventh RBS is set forth in SEQ ID NO: 6. 5. The kit of claim 1 , further comprising: (viii) a polynucleotide encoding a deoxyxylulose-5-phosphate synthase (DXS) operatively linked to an eighth RBS. 6. The kit of claim 5 , wherein said eighth RBS is set forth in SEQ ID NO: 6. 7. The kit of claim 1 , wherein said plurality of polynucleotide sequences are comprised in a single expression vector. 8. The kit of claim 1 , wherein said plurality of polynucleotide sequences are comprised in a plurality of expression vectors. 9. The kit of claim 1 , wherein said plurality of polynucleotide sequences comprise the sequence as set forth in SEQ ID NO: 8 upstream of each of said RBS. 10. A bacterial cell comprising: (i) a polynucleotide which encodes Phytoene dehydrogenase (crtI) operatively linked to a first ribosome binding site (RBS); (ii) a polynucleotide which encodes Beta-lycopene cyclase (lcy-B) operatively linked to a second RBS; (iii) a polynucleotide which encodes Beta-carotene ketolase (crtW) operatively linked to a third RBS; (iv) a polynucleotide which encodes Isopentenyl pyrophosphate (idi) operatively linked to a fourth RBS; (v) a polynucleotide which encodes Geranylgeranyl pyrophosphate synthase (crtE) operatively linked to a fifth RBS; (vi) a polynucleotide which encodes Prephytoene pyrophosphate synthase operatively linked to a sixth RBS; and (vii) a polynucleotide which encodes Beta-carotene hydroxylase (crtZ) operatively linked to a seventh RBS, wherein the second RBS and the third RBS enhance expression of an operatively linked fluorescent reporter polypeptide sequence in a vector within a suitable host cell at least five times more than the first RBS enhances expression of said operatively linked fluorescent reporter polypeptide sequence in the same position of said vector in said host cell, as measured by flow cytometry.

Assignees

Inventors

Classifications

  • Vectors or expression systems specially adapted for E. coli · CPC title

  • Geranylgeranyl diphosphate synthase (2.5.1.29) · CPC title

  • C12P23/00Primary

    Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing heterorings C12P17/00) · CPC title

  • transferring alkyl or aryl groups, other than methyl groups (2.5.1) · CPC title

  • transferring alkyl or aryl groups other than methyl groups (2.5) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9719122B2 cover?
A plurality of isolated polynucleotide sequences encoding enzymes of the astaxanthin pathway is disclosed. The polynucleotides include: (i) a polynucleotide which encodes Phytoene dehydrogenase (crtI) and a first transcriptional regulatory sequence; (ii) a polynucleotide which encodes Beta-lycopene cyclase (lcy-B) and a second transcriptional regulatory sequence; (iii) a polynucleo…
Who is the assignee on this patent?
Yeda Res & Dev
What technology area does this patent fall under?
Primary CPC classification C12P23/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).